Luigi Mangione plans to assert a psychiatric defense in his New York state murder trial for the killing of Brian Thompson [1].
The strategy shifts the focus of the legal proceedings toward Mangione's mental state. This approach could potentially mitigate his culpability for the death of the UnitedHealthcare CEO.
The defense strategy was announced Wednesday, June 17, 2026 [2]. Mangione is accused of killing Thompson in 2024 [3]. The trial is proceeding in a New York state court [4].
Legal representatives for Mangione said he was under "extreme emotional disturbance" at the time of the killing [5]. According to the defense team, this is a recognized psychiatric condition that can influence the legal outcome of the case [6].
The case has drawn significant attention due to the profile of the victim. Brian Thompson served as the chief executive of one of the largest health insurance providers in the U.S. [1].
By asserting this defense, the legal team aims to present evidence regarding Mangione's psychological health during the period of the crime. The court will determine if this condition meets the legal threshold to reduce the charges, or the resulting sentence [6].
“Mangione plans to assert a psychiatric defense”
The use of an 'extreme emotional disturbance' defense in New York law typically seeks to reduce a charge from murder to manslaughter. By focusing on the defendant's psychiatric state, the defense is attempting to move the narrative from a premeditated act to one driven by a mental health crisis, which may lead to a more lenient sentence if proven.
